Market Overview

Nabriva Therapeutics plc - Ordinary Shares (NBRV)

0.44 +0.01 (3.04%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2021
After-Hours
EPS:
REV:
-0.09
1.291M



Q2 2021
After-Hours
EPS:
REV:




Q1 2021
After-Hours
EPS:
REV:
-0.25
789K



Q4 2020
Pre-Market
EPS:
REV:
-0.29
333K



Q3 2020
After-Hours
EPS:
REV:
-0.24
6.92M
-0.10
450K
-0.09
1.291M
10%
186.89%
Q2 2020
After-Hours
EPS:
REV:
-0.30
525K
-0.16
400K
-0.14
487K
12.5%
21.75%
Q1 2020
After-Hours
EPS:
REV:
-0.29
1.703M
-0.26
460K
-0.25
789K
3.85%
71.52%
Q4 2019
Pre-Market
EPS:
REV:
-0.46
1.122M
-0.33
1.83M
-0.29
333K
12.12%
-81.8%
Q3 2019
After-Hours
EPS:
REV:
-0.79
1.468M
-0.28
1.05M
-0.24
6.92M
14.29%
559.05%
Q2 2019
Pre-Market
EPS:
REV:
-0.30
525K

-0.30
525K

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!